COMMUNIQUÉS West-GlobeNewswire

PSIQ Expects Strong Revenue Growth in 2019 as President Trump Signs Farm Bill Legalizing Hemp CBD Nationwide
27/12/2018
SUNRISE, Fla., Dec. 27, 2018 (GLOBE NEWSWIRE) -- Profile Solutions, Inc. (OTC Pink: PSIQ) announces based upon strong product demand for its Products, PSIQ is on the path toward significant revenue growth in 2019 as [...]
ICU Medical, Inc. to Present at the 37th J.P. Morgan Healthcare Conference
27/12/2018
SAN CLEMENTE, Calif., Dec. 27, 2018 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care [...]
Retrophin Doses First Patient in Pivotal Phase 3 PROTECT Study of Sparsentan for the Treatment of IgA Nephropathy
27/12/2018
SAN DIEGO, Dec. 27, 2018 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced that the first patient has been dosed in the PROTECT Study, a global, pivotal Phase 3 clinical trial evaluating the long-term [...]
MannKind Corporation to Hold Investor Conference Call
27/12/2018
- Scheduled for Friday, January 4, 2019 at 9 AM ET - WESTLAKE VILLAGE, Calif., Dec. 27, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) will host a conference call on Friday, January 4, 2019 to discuss [...]
IBEX Grants Stock Options
27/12/2018
MONTREAL, Québec, Dec. 27, 2018 (GLOBE NEWSWIRE) -- IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) announces that on December 22, 2018, its Board of Directors granted 300,000 stock options to its [...]
NanoVibronix Announces Expanded Agreement with MDS Pharm Ltd. to Include Distribution of UroShield® in Israel
27/12/2018
ELMSFORD, N.Y., Dec. 27, 2018 (GLOBE NEWSWIRE) -- NanoVibronix, Inc., (NASDAQ: NAOV) , a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, [...]
BrainStorm Issues 2018 Letter to Shareholders
27/12/2018
NEW YORK, Dec. 27, 2018 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today issued a Letter to shareholders. [...]
BeyondSpring Announces Positive Pre-NDA Meeting with the U.S. FDA for its Lead Asset, Plinabulin
27/12/2018
Company On Track to Submit New Drug Applications for Non-Small Cell Lung Cancer and Chemotherapy-Induced Neutropenia in the United States and China NEW YORK, Dec. 27, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: [...]
VIVUS to Present at Biotech Showcase on January 9, 2019
27/12/2018
CAMPBELL, Calif., Dec. 27, 2018 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS) (the “Company”), a specialty pharmaceutical company committed to the development and commercialization of innovative therapies focusing on [...]
Myriad Genetics to Present at the 37th Annual J.P. Morgan Healthcare Conference
27/12/2018
SALT LAKE CITY, Dec. 27, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN) announced today that Mark C. Capone, president and CEO, Myriad Genetics, is scheduled to present at the 37 th annual J.P. Morgan [...]
Blood donors encouraged to keep appointments to help patients this holiday season
27/12/2018
OTTAWA, Dec. 27, 2018 (GLOBE NEWSWIRE) -- Canadian Blood Services is asking donors to keep their appointments to give blood during the holidays to help ensure blood and blood products are available for those in need. On [...]
La Société canadienne du sang encourage les donneurs à respecter leur rendez-vous
27/12/2018
OTTAWA, 27 déc. 2018 (GLOBE NEWSWIRE) -- La Société canadienne du sang demande aux donneurs qui ont un rendez-vous pendant la période des Fêtes de respecter leur engagement. Il est important que les donneurs se [...]
G1 Therapeutics to Present at 37th Annual J.P. Morgan Healthcare Conference
27/12/2018
RESEARCH TRIANGLE PARK, N.C., Dec. 27, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today announced that Chief Executive Officer Mark Velleca, M.D., Ph.D., will [...]
Cyclacel Pharmaceuticals to Present at Biotech Showcase™ 2019 in San Francisco
27/12/2018
BERKELEY HEIGHTS, N.J., Dec. 27, 2018 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC, Nasdaq:CYCCP) ("Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on [...]
Axsome Therapeutics Provides Year End 2018 Clinical Update
27/12/2018
FDA clearance of IND received for Phase 2 trial of AXS-12 in narcolepsy Phase 2 results of AXS-05 in major depressive disorder on track for early January 2019 Phase 3 results of AXS-05 in treatment resistant depression [...]
Osmotica Pharmaceuticals Appoints Seasoned Financial Executive Gregory Cowan to Board of Directors and Audit Committee
27/12/2018
BRIDGEWATER, N.J., Dec. 27, 2018 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (“Osmotica” or the “Company”) (Nasdaq: OSMT), a fully integrated biopharmaceutical company, today announced that Gregory Cowan, a [...]
HEXO reaches construction and licensing milestones for its massive 1 million sq. ft. greenhouse – on time and on budget
27/12/2018
GATINEAU, Quebec, Dec. 27, 2018 (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO” or the “Company”) (TSX: HEXO ) has reached a construction and licensing milestone with the first phase of its 1 million sq. ft. greenhouse expansion [...]
HEXO atteint des jalons concernant sa serre d’un million de pieds carrés – construction et octroi de licence – selon les délais et le budget prévus
27/12/2018
GATINEAU, Québec, 27 déc. 2018 (GLOBE NEWSWIRE) -- HEXO Corp (« HEXO » ou la « Société ») (TSX: HEXO ) a franchi une étape importante touchant la première phase de l’agrandissement d’un million de pieds carrés de sa [...]
Transactions in relation to share buyback program
27/12/2018
Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 2, 2018, in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]

Pages